April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Rami Manochakian: Zongertinib in Previously Treated HER2-Mutant NSCLC
Apr 29, 2025, 13:57

Rami Manochakian: Zongertinib in Previously Treated HER2-Mutant NSCLC

Rami Manochakian, Vice President of the North American Neuroendocrine Tumor Society, shared an article on X:

Just published in NEJM. Results of: Beamion LUNG-1 phase 1a–1b of: Zongertinib (Oral, irreversible, HER2 TKI) in previously treated Patients with advanced HER2-mutant non-small- cell Lung Cancer (NSCLC).

Zongertinib in Previously Treated HER2-Mutant Non–Small-Cell Lung Cancer

Authors: John V. Heymach et al.

Rami Manochakian